Procaps Group is a prominent player in the pharmaceutical and nutraceutical industry, operating in more than 50 countries across the globe. With a keen focus on sustainability, the company has amassed a workforce of over 5,500 individuals and direct operations in 13 countries within the Americas. Established in 1977, Procaps specializes in the development, manufacturing, and marketing of a wide range of pharmaceutical products, including over-the-counter and prescription drugs, as well as nutritional supplements and high-potency clinical solutions.
Procaps Group's extensive reach and diversified product portfolio position it as a key player in the manufacturing and pharmaceutical sectors. As a publicly traded company listed on NASDAQ under the symbol PROC, it offers investors an opportunity to engage with a company that has a proven track record of success and a wide-ranging global presence in the pharma industry.
Senores Pharmaceuticals Limited